![ViroVet and The Pirbright Institute are first to demonstrate efficacy of antivirals in ASFV – African Swine Fever Virus – infected pigs](https://www.seventure.fr/wp-content/uploads/2020/07/10_104270789-322x211.jpg)
9 September 2021
ViroVet and The Pirbright Institute are first to demonstrate efficacy of antivirals in ASFV – African Swine Fever Virus – infected pigs
Belgian biotechnology company ViroVet partnered with researchers at The Pirbright Institute in 2019 to develop and test the first antiviral drugs that act against African swine...